Newron Pharma to acquire Hunter-Fleming in all share transaction

Newron Pharmaceuticals SpA, the Italian biopharmaceutical company, is to acquire Hunter-Fleming Ltd., a privately-held British company focused on neurodegenerative and inflammatory disorders, in an all-share transaction.